South San Francisco, CA (TOSOH) August 24,2009 – Tosoh Bioscience was busy at last month’s annual AACC meeting in Chicago as the company introduced it’s latest advancement in high throughput immunoassay testing – the AIA-2000 Automated Immunoassay Analyzer. The advanced system features a wealth of cutting-edge features as it builds upon Tosoh’s industry-wide reputation as a respected developer of reliable diagnostic systems for Immunoassay and HPLC Testing.
Tosoh Bioscience also sponsored educational seminars at the AACC meeting by renowned Clinical Chemist David Plaut. The seminars covered a wide array of pertinent topics in the field of Clinical Diagnostics including quality control, result accuracy, HbA1c, Cardiac Markers, PTH and Tumor Markers.
AACC Educational Seminars by David Plaut at Tosoh Booth
Introduced with a high level of anticipation, the AIA-2000 was very well received by hospitals and laboratories looking for a high throughput Immunoassay analyzer. The AIA-2000 provides many operational improvements which can result in overall laboratory productivity. Continue reading »
South San Francisco, CA (TOSOH) – August 11, 2009 – Clinical diagnostics pioneer Tosoh Bioscience is looking to America’s favorite pastime for inspiration through global economic challenges. A world leader in the development of high quality products for immunoassay and HPLC testing, Tosoh Bioscience maintains that healthy activities and community support are more important than ever. Tosoh has sponsored two local little league baseball teams this year, and capped off the season with a company outing at a San Francisco Giants game.
According to Jimmy Williams, Director of Sales and Marketing, “The game of baseball is inspiring as it teaches us that there are many ups and downs along the road to victory. The great team players persevere and work harder to overcome obstacles.”
Tosoh’s sponsorship of little league baseball coincides with the company’s commitment to supporting the local community. Williams states, “Though Tosoh is a large global corporation, it is extremely important for our organization’s longevity to have a positive presence in the community.”
With a state-of-the-art product line for immunoassay and HPLC testing, Tosoh Bioscience has continued to experience growth in the North and South American clinical diagnostics markets. Recently Tosoh launched the AIA-2000 for high throughput immunoassay testing. Also, the Tosoh G8 HPLC analyzer provides gold standard accuracy for HbA1c measurement in diabetes monitoring.
June 7, 2009 … At AACC 2009 Annual Meeting in Chicago, IL, Tosoh Bioscience (Booth #3140) will feature advancements in immunoassay and HPLC testing.Events from Tosoh Bioscience include free educational seminars by David Plaut on the booth stage.Plaut’s annual AACC educational seminars are eagerly anticipated as a source of pertinent information from immunoassay and HPLC testing.Also, David provides immunoassay and HPLC case studies for reference.David Plaut will give free CDs of his seminar information to attendees.
AACC 2009 PRODUCT SHOWCASESThere will also be excitement revolving around the Tosoh product line at AACC 2009, as Tosoh will be introducing a new analyzer for immunoassay testing: the AIA-2000 Automated Immunoassay Analyzer.With a throughput of 200 tests per hour, the AIA-2000 provides all the speed and flexibility necessary to excel in high throughput laboratory testing environments.Expanded functionality has been added to the system, improving laboratory workflow and increasing walk away time.
Also for Immunoassay testing, the AIA-360 is a sophisticated system that fits in any lab environment.With a footprint of 16 X 16 X 21 inches and weighing approximately 60 lbs., the AIA-360’s compact design makes it ideal for physician office laboratories, work stations for small hospitals, STAT testing, such as cardiac panels, as well as a dedicated system for specialty testing.With a throughput of 36 tests per hour, the AIA-360 generates its first result in approximately 20 minutes.The cost effective system utilizes the same 10 minute ST reagents as Tosoh’s larger systems, making it the perfect back-up analyzer.
Tosoh’s AIA-600 II is a proven system and has earned the industry-wide reputation of high reliability for immunoassay testing.The analyzer provides big system features in a bench top analyzer.Fitting in just 30 inches of counter space, the AIA-600 II has a throughput of 60 results per hour including STAT assay results in ~18 minutes, making it an ideal solution for time-critical tests such as cardiac markers.
All Tosoh AIA immunoassay testing systems utilize the same Unit Dose Test Cup reagent format, ensuring consistent performance every time.With interchangeable reagents on all Tosoh systems, inventory management is easy and problem free.Transition from one system to another is seamless, ensuring consistent results and efficient, economical operation for the laboratory.
For HbA1c testing, Tosoh’s G8 HPLC Analyzer provides one of the industry’s lowest CVs of less than 2%. The NGSP certified instrument-reagent system utilizes the gold standard ion-exchange method for HbA1c testing to effectively monitor glycohemoglobin in diabetic patients. With a compact footprint of 21″w x 19″h x 20″d, the G8 fits easily in most laboratory environments. The G8 provides fast results with an HbA1c analysis time of only 1.6 minutes. Simple touch-screen operation, as well as automatic start-up and daily maintenance make the system extremely user-friendly.
The Tosoh G7 HPLC Analyzer can be used for both HbA1c and beta-thalassemia testing in one compact analyzer. The system provides beta-thalassemia results in less than 8 minutes with quantification of HbF and HbA2. Also, the NGSP certified G7 HPLC Analyzer delivers presumptive identification of HbS, C and D; as well as true separation of Labile and Stable A1c.
With the TRCRapid-160 (Research Use Only), Tosoh has responded to the growing need and acceptance of molecular diagnostic devices. This accurate and full-featured platform delivers accelerated real-time RNA amplification and detection by combining two innovative technologies - the isothermal TRC reaction and the unique INAF fluorescence probe.This technology features much lower reaction times than seen with traditional real-time PCR. This instrument has the potential to be used in many testing areas, such as infectious diseases, cancer markers and environmental testing.
In 2009, Tosoh Bioscience, Inc. is celebrating 20 years in the diagnostic industry.Started in 1989 as Tosoh Medics, Inc., the company is committed to providing quality diagnostic systems and priority service to laboratory customers.TBI has sustained double digit growth over the past 8 years, surpassing the industry growth of ~ 4%, with 2008 being the most successful year to date.Sales of Tosoh Bioscience analyzers and assays have grown consistently throughout the years.
